ArticleJournal of immunotherapy and precision oncology2023

Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus.

Viraj A Master et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.